Through organic growth, commercialisation of the existing product pipeline and a novel approach to R&D and licensing, DermaSalve is delivering a high growth, high value company with a broad but clearly focused product platform.
3.00p 0.00p on 22/11/08
More...
Annual Report (2006) PDF
Financial information provided by Hemscott Group